| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |